THE EFFECT OF CLOZAPINE ON FOS PROTEIN IMMUNOREACTIVITY IN THE RAT FOREBRAIN IS NOT MIMICKED BY THE ADDITION OF ALPHA(1)-ADRENERGIC OR 5HT(2) RECEPTOR BLOCKADE TO HALOPERIDOL

被引:31
作者
FINKJENSEN, A
LUDVIGSEN, TS
KORSGAARD, N
机构
[1] Health Care Discovery, Novo Nordisk A/S, DK-2760 Måløv, Novo Nordisk Park
关键词
FOS PROTEIN; IMMUNOHISTOCHEMISTRY; PREFRONTAL CORTEX; DORSOLATERAL STRIATUM; NUCLEUS ACCUMBENS; NEUROLEPTICS;
D O I
10.1016/0304-3940(95)11731-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The involvement of alpha(1)-adrenergic and 5HT(2)-receptor blockade in the induction of Fos protein produced by the 'atypical' neuroleptic clozapine was investigated in the rat forebrain. The Fos protein immunohistochemical technique has been used to identify the anatomical substrate underlying the effects of typical and atypical neuroleptics. Clozapine (20 mg/kg) induced a significantly higher Fos protein immunoreactivity response in the medial prefrontal cortex and a significantly lower response in the dorsolateral striatum compared to the effect of haloperidol (1 mg/kg). The alpha(1)-adrenergic antagonist prazosin (0.3 and 1.0 mg/kg) and the 5HT(2) antagonist ritanserin (1 and 3 mg/kg) did not increase Fos protein immunoreactivity by themselves and did not mimic the clozapine response when co-administered with haloperidol (1 mg/kg). Consequently, this study suggests that neither alpha(1)-adrenergic receptor blockade nor the 5HT(2)-receptor blockade accounts for the unique Fos protein expression pattern produced by clozapine.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 17 条
[1]  
CHIODO LA, 1985, J NEUROSCI, V5, P2539
[2]   REGIONALLY SPECIFIC EFFECTS OF ATYPICAL ANTIPSYCHOTIC-DRUGS ON STRIATAL FOS EXPRESSION - THE NUCLEUS-ACCUMBENS SHELL AS A LOCUS OF ANTIPSYCHOTIC ACTION [J].
DEUTCH, AY ;
LEE, MC ;
IADAROLA, MJ .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1992, 3 (04) :332-341
[3]   RITANSERIN, A SELECTIVE 5-HT(2/1C) ANTAGONIST, AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - A PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL [J].
DUINKERKE, SJ ;
BOTTER, PA ;
JANSEN, AAI ;
VANDONGEN, PAM ;
VANHAAFTEN, AJ ;
BOOM, AJ ;
VANLAARHOVEN, JHM ;
BUSARD, HLSM .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :451-455
[4]   EFFECTS OF TYPICAL AND ATYPICAL NEUROLEPTICS ON FOS PROTEIN EXPRESSION IN THE RAT FOREBRAIN [J].
FINKJENSEN, A ;
KRISTENSEN, P .
NEUROSCIENCE LETTERS, 1994, 182 (01) :115-118
[5]  
GARDNER EL, 1994, J CLIN PSYCHIAT, V55, P15
[6]   CLOZAPINES FUNCTIONAL MESOLIMBIC SELECTIVITY IS NOT DUPLICATED BY THE ADDITION OF ANTICHOLINERGIC ACTION TO HALOPERIDOL - A BRAIN-STIMULATION STUDY IN THE RAT [J].
GARDNER, EL ;
WALKER, LS ;
PAREDES, W .
PSYCHOPHARMACOLOGY, 1993, 110 (1-2) :119-124
[7]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[8]   SELECTIVE-INHIBITION OF MESOLIMBIC DOPAMINE RELEASE FOLLOWING CHRONIC ADMINISTRATION OF CLOZAPINE - INVOLVEMENT OF ALPHA-1-NORADRENERGIC RECEPTORS DEMONSTRATED BY INVIVO VOLTAMMETRY [J].
LANE, RF ;
BLAHA, CD ;
RIVET, JM .
BRAIN RESEARCH, 1988, 460 (02) :398-401
[9]   INTERACTION OF ANTIPSYCHOTIC-DRUGS WITH NEUROTRANSMITTER RECEPTOR-SITES IN-VITRO AND IN-VIVO IN RELATION TO PHARMACOLOGICAL AND CLINICAL EFFECTS - ROLE OF 5HT(2) RECEPTORS [J].
LEYSEN, JE ;
JANSSEN, PMF ;
SCHOTTE, A ;
LUYTEN, WHML ;
MEGENS, AAHP .
PSYCHOPHARMACOLOGY, 1993, 112 (01) :S40-S54
[10]   THE MECHANISM OF ACTION OF NOVEL ANTIPSYCHOTIC-DRUGS [J].
MELTZER, HY .
SCHIZOPHRENIA BULLETIN, 1991, 17 (02) :263-287